Study Demonstrates Potential Utility of Combination Antiviral Drug Therapies, to Treat Patients with Chronic Illnesses such as Fibromyalgia and Irritable Bowel Syndrome ATLANTA--(BUSINESS WIRE)--Virios Therapeutics, Inc. (Nasdaq: VIRI), a development-stage biotechnology company focused on advancing novel, combination antiviral therapies to treat debilitating chronic diseases, including fibromyalgia, today announced the results of a pilot… Read More..

Tegoprubart was well-tolerated, with no drug-related serious adverse events Dose dependent target engagement was demonstrated, and ALS associated pro-inflammatory biomarkers were both observed and significantly reduced in a dose dependent manner Target engagement and level of pro-inflammatory biomarker reduction were associated with a trend in the slowing of disease progression… Read More..

-Backlog Increased 38% Year-over-Year – -Conference Call Tuesday, May 24, 2022 at 10:00am EST – MILTON, NY - May 24, 2022 - Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today reported financial results for its fourth quarter and fiscal year 2022, ended February 28, 2022… Read More..